Related Experiment Video
Updated: May 1, 2026
07:14
Fabrication of a Biomimetic Nano-Matrix with Janus Base Nanotubes and Fibronectin for Stem Cell Adhesion
Published on: May 10, 2020
3.3K
A nanostructured synthetic collagen mimic for hemostasis
Vivek A Kumar1, Nichole L Taylor, Abhishek A Jalan
1Department of Chemistry, Department of Bioengineering, Rice University , Houston, Texas 77030, United States.
Biomacromolecules
|April 4, 2014
Summary
Synthetic collagen peptides (KOD) mimic natural collagen's structure and function in blood clotting. These novel biomaterials show potential as effective hemostats with reduced inflammatory responses.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Biochemistry
Background:
- Collagen, a key extracellular matrix component, is vital for hemostasis, wound healing, and tissue repair.
- Animal-derived collagen, while clinically used, presents challenges including immunogenicity, batch variability, and disease transmission risks.
- Synthetic collagen mimetics are sought after to overcome limitations of natural collagen.
Purpose of the Study:
- To evaluate a novel synthetic collagen mimetic peptide (KOD) as a biomimetic matrix for hemostasis.
- To assess the thrombotic potential and inflammatory profile of the KOD peptide matrix.
- To explore the utility of synthetic collagen mimetics in clinical applications.
Main Methods:
- Design and self-assembly of a 36-amino acid collagen mimetic peptide (KOD) into nanofibrous hydrogels.
- Assessment of platelet adhesion and activation (soluble P-selectin) on KOD matrices.
- Evaluation of plasma and whole blood clotting capabilities of KOD matrices.
- Analysis of pro-inflammatory cytokine (TNF-α, IL-1β) production by monocytes incubated with KOD.
Main Results:
- KOD peptide self-assembled into nanofibrous triple helices forming a hydrogel matrix.
- KOD matrices demonstrated effective platelet adhesion and activation, similar to animal-derived collagen.
- The synthetic collagen mimetic successfully clotted plasma and whole blood.
- Incubation with KOD peptides resulted in minimal pro-inflammatory cytokine release from monocytes.
Conclusions:
- The nanofibrous KOD peptide matrix effectively mimics natural collagen's hemostatic properties.
- This synthetic collagen mimetic exhibits a reduced inflammatory profile compared to animal-derived collagen.
- KOD represents a promising synthetic biomaterial for hemostatic applications.
